Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

USA - NYSE:ACVA - US00091G1040 - Common Stock

10.01 USD
-0.32 (-3.1%)
Last: 9/12/2025, 8:04:00 PM
10.05 USD
+0.04 (+0.4%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

3

Overall ACVA gets a fundamental rating of 3 out of 10. We evaluated ACVA against 84 industry peers in the Commercial Services & Supplies industry. ACVA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ACVA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ACVA has reported negative net income.
ACVA had a positive operating cash flow in the past year.
ACVA had negative earnings in each of the past 5 years.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

ACVA has a Return On Assets of -5.65%. This is in the lower half of the industry: ACVA underperforms 67.86% of its industry peers.
ACVA has a worse Return On Equity (-14.32%) than 64.29% of its industry peers.
Industry RankSector Rank
ROA -5.65%
ROE -14.32%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

ACVA has a better Gross Margin (53.10%) than 94.05% of its industry peers.
In the last couple of years the Gross Margin of ACVA has grown nicely.
ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACVA has more shares outstanding than it did 1 year ago.
ACVA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACVA is higher compared to a year ago.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.58, we must say that ACVA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACVA (1.58) is worse than 64.29% of its industry peers.
The Debt to FCF ratio of ACVA is 3.13, which is a good value as it means it would take ACVA, 3.13 years of fcf income to pay off all of its debts.
ACVA has a Debt to FCF ratio of 3.13. This is in the better half of the industry: ACVA outperforms 71.43% of its industry peers.
ACVA has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ACVA has a Debt to Equity ratio (0.42) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Altman-Z 1.58
ROIC/WACCN/A
WACC8.27%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ACVA has a Current Ratio of 1.59. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.59, ACVA is in line with its industry, outperforming 55.95% of the companies in the same industry.
ACVA has a Quick Ratio of 1.59. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
ACVA has a better Quick ratio (1.59) than 65.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.02% over the past year.
Looking at the last year, ACVA shows a very strong growth in Revenue. The Revenue has grown by 30.08%.
Measured over the past years, ACVA shows a very strong growth in Revenue. The Revenue has been growing by 42.93% on average per year.
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)30.08%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%

3.2 Future

Based on estimates for the next years, ACVA will show a very strong growth in Earnings Per Share. The EPS will grow by 45.81% on average per year.
ACVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.75% yearly.
EPS Next Y42.63%
EPS Next 2Y39.74%
EPS Next 3Y41.6%
EPS Next 5Y45.81%
Revenue Next Year21.22%
Revenue Next 2Y20.57%
Revenue Next 3Y20.72%
Revenue Next 5Y19.75%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACVA. In the last year negative earnings were reported.
Also next year ACVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

ACVA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACVA is cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.91
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as ACVA's earnings are expected to grow with 41.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.74%
EPS Next 3Y41.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACV AUCTIONS INC-A

NYSE:ACVA (9/12/2025, 8:04:00 PM)

After market: 10.05 +0.04 (+0.4%)

10.01

-0.32 (-3.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners104.27%
Inst Owner Change3.06%
Ins Owners2.46%
Ins Owner Change3.04%
Market Cap1.72B
Analysts84
Price Target20.27 (102.5%)
Short Float %7.16%
Short Ratio5.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.78%
Min EPS beat(2)23.94%
Max EPS beat(2)35.62%
EPS beat(4)3
Avg EPS beat(4)16.19%
Min EPS beat(4)-9.21%
Max EPS beat(4)35.62%
EPS beat(8)6
Avg EPS beat(8)9.46%
EPS beat(12)10
Avg EPS beat(12)18.85%
EPS beat(16)13
Avg EPS beat(16)15.67%
Revenue beat(2)0
Avg Revenue beat(2)-2.4%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-1.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)4.71%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)4
Avg Revenue beat(12)0.08%
Revenue beat(16)7
Avg Revenue beat(16)1.14%
PT rev (1m)-14.05%
PT rev (3m)-13.74%
EPS NQ rev (1m)-25.71%
EPS NQ rev (3m)-23.08%
EPS NY rev (1m)4.59%
EPS NY rev (3m)11.64%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-2.2%
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.44
P/FCF 28.91
P/OCF 17.54
P/B 3.84
P/tB 16.69
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.35
FCFY3.46%
OCF(TTM)0.57
OCFY5.7%
SpS4.11
BVpS2.61
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.65%
ROE -14.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.1%
FCFM 8.43%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Debt/EBITDA N/A
Cap/Depr 92.97%
Cap/Sales 5.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 1.58
F-Score6
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y42.63%
EPS Next 2Y39.74%
EPS Next 3Y41.6%
EPS Next 5Y45.81%
Revenue 1Y (TTM)30.08%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%
Revenue Next Year21.22%
Revenue Next 2Y20.57%
Revenue Next 3Y20.72%
Revenue Next 5Y19.75%
EBIT growth 1Y26.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year185.53%
EBIT Next 3Y70.4%
EBIT Next 5Y45.06%
FCF growth 1Y1113.5%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y373.93%
OCF growth 3Y-8.47%
OCF growth 5YN/A